Stocks of Illumina Inc (NASDAQ:ILMN) traded higher last session on Wall Street, down -4.96% to $95.20.
According to the data, Illumina Inc (NASDAQ:ILMN) has 22 analysts covering its stock. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $260.00 and a low of $50.00, we find $140.00. Given the previous closing price of $100.17, this indicates a potential upside of 39.76 percent. ILMN stock price is now -25.24% away from the 50-day moving average and -47.73% away from the 200-day moving average. The market capitalization of the company currently stands at $15.12B.
A total of 9 analysts have issued a hold rating and 9 have given it a buy rating. Brokers who have rated the stock have averaged $140.36 as their price target over the next twelve months.
With the price target reduced from $210 to $120, Canaccord Genuity Downgraded its rating from Buy to Hold for Illumina Inc (NASDAQ: ILMN).
In other news, Hoyt Aimee L, SVP, Chief People Officer sold 315 shares of the company’s stock on Nov 07. The stock was sold for $35,545 at an average price of $112.84. Upon completion of the transaction, the SVP, Chief People Officer now directly owns 8,314 shares in the company, valued at $0.79 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 22, SVP, Chief Commercial Officer TOUSI SUSAN H sold 500 shares of the business’s stock. A total of $83,520 was realized by selling the stock at an average price of $167.04. This leaves the insider owning 45,524 shares of the company worth $4.33 million. Insiders disposed of 44,191 shares of company stock worth roughly $4.21 million over the past 1 year. A total of 0.43% of the company’s stock is owned by insiders.
Thursday’s opening bell rang with an opening price of $100.19 for Illumina Inc (NASDAQ: ILMN). During the past 12 months, Illumina Inc has had a low of $89.00 and a high of $238.71. As of last week, the company has a debt-to-equity ratio of 0.39, a current ratio of 1.69, and a quick ratio of 1.28. The fifty day moving average price for ILMN is $126.06 and a two-hundred day moving average price translates $181.52 for the stock.
The latest earnings results from Illumina Inc (NASDAQ: ILMN) was released for Sep, 2023. According to the Diagnostics & Research Company, earnings per share came in at $0.33, beating analysts’ expectations of $0.12 by 0.21. This compares to -$24.31 EPS in the same period last year. The net profit margin was -25.20% and return on equity was -17.82% for ILMN. The company reported revenue of $1.12 billion for the quarter, compared to $1.11 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 0.36 percent. For the current quarter, analysts expect ILMN to generate $1.07B in revenue.
Illumina Inc(ILMN) Company Profile
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
